CELLDEX THERAPEUTICS, INC.; INC.;CELLDEX THERAPEUTICS;UNIVERSITY OF IOWA RESEARCH FOUNDATION
发明人:
SMITH, RICHARD, J.H.,ZHANG, YUZHOU,MARSH, HENRY, C.
申请号：
EP11825951
公开号：
EP2616092A4
申请日:
2011.09.15
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
A method is disclosed for treating nephropathies involving undesired alternative pathway complement activation by administration of a complement inhibitory protein such as soluble complement receptor type I (sCR1).
